PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Post-doctoral Research Associate, Sharjah Institute of Medical Research, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates.\', \'Assistant Professor, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.\', \'Ph.D Scholar and Graduate Research Assistant, Sharjah Institute of Medical Research, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.\', \'Professor, Department of Chemistry, Temple University, Philadelphia, PA, USA.\', \'Professor, Department of Microbiology and Immunology, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Director, Research Institute for Medical & Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/17460441.2021.1854221
?:doi
?:hasPublicationType
?:journal
  • Expert opinion on drug discovery
is ?:pmid of
?:pmid
?:pmid
  • 33356641
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.309
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all